<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23335706</identifier>
<setSpec>0025-7680</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cóccaro, Nicolás</dc:author>
<dc:author>Sánchez, Ariel</dc:author>
<dc:author>Bobrovsky, Eduardo</dc:author>
<dc:author>Castiglioni, Alejandro</dc:author>
<dc:author>Silva, Roberto</dc:author>
<dc:author>Moysés, Rosa M A</dc:author>
<dc:author>Graciolli, Fabiana</dc:author>
<dc:description xml:lang="en">A case of oncogenic osteomalacia in a 50-year-old male is here presented. He suffered severe bone pain and marked muscular weakness of 4 years' duration. There were several vertebral deformities in the thoracic spine, bilateral fractures of the iliopubic branches, another fracture in the left ischiopubic branch, and a Looser's zone in the right proximal tibia. An octreotide-Tc scan allowed to identify a small tumor in the posterior aspect of the right knee. It was surgically removed. Microscopically, it was a phosphaturic mesenchymal tumor-mixed connective tissue (PMT-MCT). Expression of FGF-23 was documented by immune-peroxidase staining. There was rapid improvement, with consolidation of the pelvic fractures and the tibial pseudo-fracture. The laboratory values returned to normal.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 </dc:date>
<dc:title xml:lang="es">Osteomalacia por tumor secretor de FGF-23.</dc:title>
<dc:title xml:lang="en">[Ostemalacia due to a tumor secreting FGF-23].</dc:title>
<dc:publisher>Medicina</dc:publisher>
</metadata>
</record>
</pubmed-document>
